Medivolve Inc. Pays Tribute to Strategic Advisor Larry King
TORONTO, Jan. 25, 2021
Medivolve, Inc. (“Medivolve”) (NEO:MEDV; OTC:COPRF; FRA:4NC) released a statement on the passing of its strategic advisor, Larry King. With great sadness, we honor the death of our advisor and friend. Larry King was a pioneer in broadcasting, a respected colleague, and a kind-hearted soul who was committed to working towards a better and brighter future.
When our company began, Larry saw potential in our company and promise in our work, which was focused on sustainability and the improvement of our planet. We benefited greatly from his wise counsel. Investors can watch a video interview between Medivolve advisors Dr. King and Richard Dolan on YouTube.
CC Neuberger Principal Holdings I Announces Extraordinary General Meeting Teleconference Details
News provided by
Share this article
NEW YORK, Jan. 26, 2021 /PRNewswire/ CC Neuberger Principal Holdings I (
CCNB1 ) (NYSE: PCPL), today announced that, due to the public health and safety concerns related to the coronavirus (COVID-19) pandemic and recommendations and orders from federal and New York authorities, the Company is strongly encouraging that shareholders attend the extraordinary general meeting of its shareholders, which will be held on February 2, 2021 at 9:00 a.m., New York City Time (the
General Meeting ), by teleconference rather than in person. The purpose of the General Meeting is to vote on certain proposals relating to the previously announced Business Combination Agreement, dated as of October 14, 2020 (as amended, the
Share this article
Share this article
NEW BRUNSWICK, N.J., Jan. 26, 2021 /PRNewswire/ Johnson & Johnson (NYSE: JNJ) today announced results for fourth-quarter and full year 2020. Our notable full year performance reflects the continued confidence from patients, physicians, customers and consumers in our life-enhancing products and medicines, particularly throughout the COVID-19 pandemic, said Alex Gorsky, Chairman and Chief Executive Officer. I m incredibly proud of our Johnson & Johnson teams around the world for going above and beyond to meet stakeholder needs. These efforts, and our commitment to families around the world as the largest broad-based healthcare company, enabled us to lead in the fight against COVID-19. We continue to progress our COVID-19 vaccine candidate and look forward to sharing details from our Phase 3 study soon. Johnson & Johnson was built for times like these, and I am extremely confident in our ability to deliver lasting value and continued innovat
Vibe Growth Corporation Operational Update - Record Q4 2020 Revenues and Sacramento Cultivation Expansion
Vibe Growth Corporation (
Company or
Vibe ), a vertically integrated cannabis operator, provides an operational update on preliminary unaudited fourth quarter 2020 revenues for the period ending December 31, 2020 ( Q4 2020 ). All dollar amounts in this press release are in U.S. dollars.
Q4 2020 revenue is expected to exceed $6.5 million
Q4 2020 revenue anticipated to increase 61% over the year prior period
Gross margins have increased since Q3 2020
Expansion of Sacramento cultivation
Growth in the quarter was driven primarily by increased customer visits, average consumer basket sizes, and online sales. The Company expects to report positive EBITDA in Q4 2020 due to higher sales, strong gross margins, and increased eCommerce activity. Vibe expects to release its full year 2020 financial results for the year ended December 31, 2020, by mid-April.